245 related articles for article (PubMed ID: 16136551)
1. Repeated MDMA ("Ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding.
Piper BJ; Fraiman JB; Meyer JS
Dev Psychobiol; 2005 Sep; 47(2):145-57. PubMed ID: 16136551
[TBL] [Abstract][Full Text] [Related]
2. Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period.
Piper BJ; Meyer JS
Pharmacol Biochem Behav; 2004 Dec; 79(4):723-31. PubMed ID: 15582680
[TBL] [Abstract][Full Text] [Related]
3. Increased responsiveness to MDMA in adult rats treated neonatally with MDMA.
Piper BJ; Meyer JS
Neurotoxicol Teratol; 2006; 28(1):95-102. PubMed ID: 16271852
[TBL] [Abstract][Full Text] [Related]
4. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS
J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence.
Meyer JS; Piper BJ; Vancollie VE
Ann N Y Acad Sci; 2008 Oct; 1139():151-63. PubMed ID: 18991859
[TBL] [Abstract][Full Text] [Related]
6. A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field.
Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
Psychopharmacology (Berl); 2002 Jan; 159(2):167-75. PubMed ID: 11862345
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity to the acute effects of MDMA ("ecstasy") in female rats.
Palenicek T; Votava M; Bubenikova V; Horacek J
Physiol Behav; 2005 Nov; 86(4):546-53. PubMed ID: 16233904
[TBL] [Abstract][Full Text] [Related]
8. Intermittent prenatal MDMA exposure alters physiological but not mood related parameters in adult rat offspring.
Adori C; Zelena D; Tímár J; Gyarmati Z; Domokos A; Sobor M; Fürst Z; Makara G; Bagdy G
Behav Brain Res; 2010 Jan; 206(2):299-309. PubMed ID: 19782105
[TBL] [Abstract][Full Text] [Related]
9. Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats.
Piper BJ; Ali SF; Daniels LG; Meyer JS
Synapse; 2010 Jun; 64(6):421-31. PubMed ID: 20169574
[TBL] [Abstract][Full Text] [Related]
10. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
11. Adolescent MDMA exposure diminishes the physiological and neurotoxic consequences of an MDMA binge in female rats.
Piper BJ; Henderson CS; Meyer JS
Dev Psychobiol; 2014 Jul; 56(5):924-34. PubMed ID: 24752593
[TBL] [Abstract][Full Text] [Related]
12. Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression.
Jaehne EJ; Majumder I; Salem A; Irvine RJ
Addict Biol; 2011 Jan; 16(1):7-19. PubMed ID: 20192951
[TBL] [Abstract][Full Text] [Related]
13. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding.
Schenk S; Hely L; Lake B; Daniela E; Gittings D; Mash DC
Eur J Neurosci; 2007 Dec; 26(11):3229-36. PubMed ID: 18005064
[TBL] [Abstract][Full Text] [Related]
14. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
15. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
16. Ecstasy: are animal data consistent between species and can they translate to humans?
Easton N; Marsden CA
J Psychopharmacol; 2006 Mar; 20(2):194-210. PubMed ID: 16510478
[TBL] [Abstract][Full Text] [Related]
17. Atypical development of behavioural sensitization to 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') in adolescent rats and its expression in adulthood: role of the MDMA chirality.
von Ameln N; von Ameln-Mayerhofer A
Addict Biol; 2010 Jan; 15(1):35-44. PubMed ID: 20002021
[TBL] [Abstract][Full Text] [Related]
18. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.
Stanley N; Salem A; Irvine RJ
Neuroscience; 2007 Apr; 146(1):321-9. PubMed ID: 17306465
[TBL] [Abstract][Full Text] [Related]
19. Behavioural and neurotoxic long-lasting effects of MDMA plus cocaine in adolescent mice.
Daza-Losada M; Rodríguez-Arias M; Maldonado C; Aguilar MA; Miñarro J
Eur J Pharmacol; 2008 Aug; 590(1-3):204-11. PubMed ID: 18585379
[TBL] [Abstract][Full Text] [Related]
20. MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition.
Gyongyosi N; Balogh B; Kirilly E; Kitka T; Kantor S; Bagdy G
Brain Res; 2008 Sep; 1231():34-46. PubMed ID: 18638459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
